IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study
Crossref DOI link: https://doi.org/10.1007/s00044-016-1533-y
Published Online: 2016-03-04
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Elfiky, Abdo A.
Elshemey, Wael M.
Text and Data Mining valid from 2016-03-04
Article History
Received: 8 June 2015
Accepted: 10 February 2016
First Online: 4 March 2016
Free to read: This content has been made available to all.